Prothena | Efectivo Y Equivalentes



Cash And Equivalent Cambio Fecha
Acadia Pharmaceuticals USD 755.99M 190.66M 2024-12
Agios Pharmaceuticals USD 76.25M 177.48M 2024-12
ALKERMES USD 291.15M 636.63M 2024-12
Alnylam Pharmaceuticals USD 966.43M 133.49M 2024-12
Amgen USD 11.97B 2.96B 2024-12
Biogen USD 2.38B 675.8M 2024-12
BioMarin Pharmaceutical USD 613.22M 324.54M 2024-12
Exelixis USD 217.37M 40.97M 2025-01
Incyte USD 1.69B 383.72M 2024-12
Intra Cellular Therapies USD 306.95M 157.36M 2024-12
Ionis Pharmaceuticals USD 242.08M 92.53M 2024-12
MacroGenics USD 182.84M 3.22M 2024-12
Neurocrine Biosciences USD 233M 116.1M 2024-12
Prothena USD 471.39M 47.87M 2024-12
Regeneron Pharmaceuticals USD 17.91B 15.9B 2024-12
Ultragenyx Pharmaceutical USD 173.73M 23.11M 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



Prothena Efectivo Y Equivalentes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.